跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 哲玄
助理教授
,
耳鼻喉學科
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0001-9134-3786
電子郵件
d119105002
tmu.edu
tw
h-index
137
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2024
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(25)
類似的個人檔案
(6)
指紋
查看啟用 Che-Hsuan Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Upregulation
100%
Autophagy
90%
Radiosensitivity
80%
Cancer Cell
43%
down Regulation
38%
Cell Death
38%
Luciferase
36%
Survival Rate
35%
E2F
32%
P53
30%
Messenger RNA
26%
Mammalian Target of Rapamycin
26%
Immune Checkpoints
26%
Tumor Progression
25%
STAT1
23%
Cell Invasion
23%
IC50
22%
Reverse Transcription Polymerase Chain Reaction
22%
Autophagosome
21%
Visual Acuity
19%
TXNIP
19%
Progression Free Survival
19%
CHRNA5
19%
Precursor
19%
Illumination
19%
Drive
19%
Inositol Monophosphatase
19%
Alpha Chain
19%
Guanylate-Binding Protein
19%
Nicotinic Acetylcholine Receptor
19%
DNA Polymerase
19%
Phospholipase C
19%
Histone H2A
19%
MicroRNA
19%
Gene Set Enrichment Analysis
18%
Cell Migration
14%
Western Blot
13%
Computer Model
10%
Cytotoxic Concentration
9%
Inflammasome
9%
Cell Proliferation
9%
Biological Activity
9%
Next Generation Sequencing
9%
Anticancer
8%
STAT3
7%
Interferon
7%
Anthracycline
7%
Cytotoxicity Assay
6%
Tissue Microarray
6%
Signal Transduction
6%
Medicine and Dentistry
Upregulation
46%
Nodular Melanoma
38%
Programmed Cell Death
38%
Mouth Squamous Cell Carcinoma
38%
Otorhinolaryngology
34%
Radiosensitivity
29%
Malignant Neoplasm
25%
Clear Cell Renal Cell Carcinoma
19%
down Regulation
19%
Absence
19%
Visual Acuity
19%
Lung Adenocarcinoma
19%
Inositol
19%
Oral Cancer
19%
Autophagy
19%
Ovarian Cancer
19%
Hearing Impairment
19%
Bone Conduction
19%
Glioblastoma
19%
Temozolomide
19%
STAT1 Protein
19%
Guanine Nucleotide Binding Protein
19%
Programmed Death 1 Ligand 1
19%
Paclitaxel
19%
Histone H2A
19%
Echography
19%
Medicine
19%
Sialolithiasis
19%
Voice Therapy
19%
Systematic Review
19%
Meta-Analysis
19%
Paralysis
19%
Voice
19%
Vocal Folds
19%
Paraneoplastic Pemphigus
19%
Biological Marker
15%
Decision Making
12%
Immune Checkpoint Inhibitor
12%
Radiation Therapy
10%
Squamous Cell Carcinoma Cell
10%
Cancer Cell
8%
Primary Tumor
8%
Metastatic Carcinoma
7%
Airway Management
7%
Head Impulse Test
7%
Neurology
6%
Carcinoma Cell
6%
Protein P53
6%
Mammalian Target of Rapamycin Inhibitor
6%
Medical Student
6%
Pharmacology, Toxicology and Pharmaceutical Science
Renal Cell Carcinoma
38%
Mouth Squamous Cell Carcinoma
38%
Paclitaxel
33%
Biological Marker
29%
Infection
21%
Mouse
19%
Rhus
19%
Inositol
19%
Mouth Cancer
19%
Triple Negative Breast Cancer
19%
Ovary Cancer
19%
Docetaxel
19%
Ferrous Ion
19%
Castration Resistant Prostate Cancer
19%
Gallic Acid
19%
Intervertebral Disk Degeneration
19%
Lactoferrin
19%
STAT1 Protein
19%
Melanoma
19%
Programmed Cell Death
19%
Guanine Nucleotide Binding Protein
19%
Programmed Death 1 Ligand 1
19%
Sialolithiasis
19%
DNA Polymerase
19%
Prevalence
19%
Sleep Disordered Breathing
19%
IC50
12%
Immune Checkpoint Inhibitor
12%
Luciferase
11%
Chemotherapy
11%
Malignant Neoplasm
10%
Mammalian Target of Rapamycin Inhibitor
9%
Acetic Acid Ethyl Ester
7%
Antioxidant
7%
Sialoadenitis
6%
Primary Tumor
6%
Western Blot
5%
Protein P53
5%
Postoperative Infection
5%
Backache
5%
Anaerobic Infection
5%
